07:00 , Aug 18, 2008 |  BioCentury  |  Finance

Ebb & Flow

Investors reached new heights of optimism after a special committee of three independent Genentech board members rejected Roche ’s offer to buy the 44.1% of the biotech it doesn’t own for $89 a share, or...
08:00 , Feb 28, 2005 |  BC Week In Review  |  Company News

Curacyte, IBFB deal

Curacyte merged with IBFB. The newco will be headquartered in Leipzig and have 50 employees. BioConnect advised Curacyte, while JSB Partners advised IBFB. Curacyte's lead compound is pyridoxalated hemoglobin polyoxyethylene (PHP), a nitric oxide scavenger...
02:13 , Feb 24, 2005 |  BC Extra  |  Company News

Curacyte merges with IBFB, raises EUR16.5M

Curacyte (Munich, Germany) merged with IBFB Pharma (Leipzig, Germany). The newco will be headquartered in Leipzig and have 50 employees. BioConnect advised Curacyte , while JSB Partners advised IBFB . Curacyte's lead compound is pyridoxalated...
08:00 , Jan 14, 2002 |  BioCentury  |  Finance

Europe: Old money vs. new money

2002 Financial Markets Preview Europe: Old money vs. new money Europe's private equity markets are still recovering from the over-valuation engendered by the genomics bubble. With valuations for the more mature private companies still coming...
08:00 , Nov 12, 2001 |  BioCentury  |  Finance

Sleep and dreams

News that Cephalon (CEPH) beat the third quarter consensus estimates by a more than robust $0.34 might have given the impression that analysts were asleep at the wheel. It's not every day that a company...
08:00 , Nov 5, 2001 |  BC Extra  |  Financial News

Merlin builds presence in Germany

Merlin Biosciences (London, U.K.) has taken a stake in life science investment advisory group BioConnect (Frankfurt/Main, Germany), and has established an investment advisory agreement to aid Merlin's investment activities in Europe, especially the German speaking...
08:00 , Nov 13, 2000 |  BC Extra  |  Financial News

Wilex raises EUR30 million

Wilex (Munich, Germany), a developer of cancer therapeutics, raised EUR30 million ($26 million) in a venture financing. Investors included TVM; Merlin; Julius Baer; Vontobel; BioConnect; Apax; and Earlybird....